In B cell malignancies, miR-377 reportedly targets BCL-xL and the locus miRNAs were downregulated upon chemotherapy treatment of chronic lymphocytic leukemia (CLL) patients [41]. This evidence concerns the gene BCL2L1 and B-cell chronic lymphocytic leukemia.